A Study on Mahjong Intervention to improve Cognitive Impairment in Patients with Schizophrenia: a pilot, single-blind, randomized, controlled trial

Author:

Hu Renqin1,Xie Zongli2,Li Junyao1,Luo Huirong1,Guo Yanwei1,Tan Jinglan1,Luo Qinghua1

Affiliation:

1. First Affiliated Hospital of Chongqing Medical University

2. Yubei District Hospital of Traditional Chinese Medicine

Abstract

Abstract

Objective Mahjong, a traditional Chinese tile-based game, has been widely reported to be closely associated with better cognitive function. However, its effects on the cognitive function of patients with schizophrenia have not yet been studied. Method In a pilot study, 49 patients diagnosed with schizophrenia were randomly assigned to the intervention group (Mahjong combined with standard treatment) and the control group (standard treatment). The intervention group engaged in cognitive training through Mahjong for 2 hours per day, 4 days per week for 12 weeks. Primary cognitive outcomes were assessed using Cambridge Neuropsychological Test Automated Battery (CANTAB), while secondary outcomes were evaluated with the Positive and Negative Syndrome Scale (PANSS), and the Self-report Quality of Life Measure for People with Schizophrenia (SQLS). Assessments were conducted at baseline (T0), the 4th week (T1), the 8th week (T2), and the 12th week (T3). Results There is a significant group-by-time interaction effect in RTI and time effect in PAL. The intervention group showed significant improvements in reaction time and movement time of response to a visual target, visual memory and new learning at T3 compared to baseline. Additionally, the intervention group exhibited significant improvements in SQLS over time. Conclusion While this pilot study suggests that prolonged Mahjong intervention may benefit certain cognitive functions and quality of life in patients with schizophrenia, these findings should be interpreted with caution. Further research with larger, more diverse samples and longer follow-up periods is necessary to confirm and extend these findings. Trial registration: The trial is registered with https://www.chictr.org.cn/ under registration number ChiCTR2400083439 (date of registration: 2024-01-25).

Publisher

Springer Science and Business Media LLC

Reference82 articles.

1. Global regional. and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The lancet Psychiatry 2022, 9(2):137–150.

2. Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art;Harvey PD;Schizophrenia Res Cognition,2022

3. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond;Bora E;Schizophr Bull,2010

4. Cognitive impairment in people with schizophrenia: an umbrella review;Gebreegziabhere Y;Eur Arch Psychiatry Clin NeuroSci,2022

5. Schizophrenia is a cognitive illness: time for a change in focus;Kahn RS;JAMA psychiatry,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3